FLGT (Fulgent Genetics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Fulgent Genetics, Inc. Common Stock (FLGT) is a publicly traded Healthcare sector company. As of May 21, 2026, FLGT trades at $16.36 with a market cap of $450.15M and a P/E ratio of 0.00. FLGT moved +2.92% today. Year to date, FLGT is -35.32%; over the trailing twelve months it is -22.67%. Its 52-week range spans $13.46 to $31.04. Analyst consensus is buy with an average price target of $18.50. Rallies surfaces FLGT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns FLGT stock?
Hedge funds tracked by Rallies that own FLGT include Panagora Asset and Bridgewater Associates. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Fulgent Genetics, Inc. Common Stock.
FLGT Key Metrics
Key financial metrics for FLGT
Metric
Value
Price
$16.36
Market Cap
$450.15M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$31.04
52-Week Low
$13.46
Volume
75
Avg Volume
0
Revenue (TTM)
$320.35M
Net Income
$-75.01M
Gross Margin
38.71%
Top Hedge Funds Holding FLGT
Panagora Asset holds 18.99K shares of FLGT, changed +0.00% as of Dec 31, 2025.
Bridgewater Associates holds 18.90K shares of FLGT, changed -13.35% as of Mar 31, 2024.
Hedge funds tracked by Rallies that own FLGT include Panagora Asset and Bridgewater Associates. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Fulgent Genetics, Inc. Common Stock.
Does Rallies show 13F holders for FLGT?
Yes. Rallies tracks hedge fund and 13F ownership data for FLGT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is FLGT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FLGT. It does not provide personalized investment advice.
